Sunil G. Babu
Fort Wayne Medical Oncology And Hematology, Fort Wayne
Fort, MH, India
Fort, MH, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Ropeginterferon alfa-2b-njft treatment in essential thrombocythemia across different driver mutations: results from a North American, single-arm, multicentre study (EXCEED-ET).
Journal: Lancet regional health. Americas
Published: March 25, 2026
A multicenter study to assess efficacy, safety, and tolerability of ropeginterferon alfa-2b-njft in patients with essential thrombocythemia in the US and Canada: EXCEED-ET trial.
Journal: Frontiers in medicine
Published: January 11, 2025
Outcomes in Patients with Poor-Risk Cytogenetics with or without TP53 Mutations Treated with Venetoclax and Azacitidine.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 20, 2022
Improvements in Health-related Quality of Life and Symptoms in Patients With Previously Untreated Chronic Lymphocytic Leukemia: Final Results From the Phase II GIBB Study of the Combination of Obinutuzumab and Bendamustine.
Journal: Clinical lymphoma, myeloma & leukemia
Published: May 20, 2021
Phase 2, multicenter GIBB study of obinutuzumab plus bendamustine in previously untreated patients with chronic lymphocytic leukemia.
Journal: Leukemia & lymphoma
Published: November 27, 2020
The efficacy of diagnostic battery in Pott's disease: A prospective study.
Journal: Indian journal of orthopaedics
Published: March 07, 2014
KIT proto-oncogene exon 8 deletions at codon 419 are highly frequent in acute myeloid leukaemia with inv(16) in Indian population.
Journal: Molecular biotechnology
Published: July 25, 2012
Screening of the c-kit gene missense mutation in invasive ductal carcinoma of breast among north Indian population.
Journal: Molecular biology reports
Published: November 17, 2011
Showing 1-10 of 10
Last Updated: 09/26/2026